Source :Ronnick Fong, Hangzhou DE Mark Industrial Co Ltd
A total of 202 enterprises in China have approval licences for the production of vet APIs.
From the below chart, we can see that the regional distribution of vet APIs enterprises is mainly concentrated in the eastern and central regions of China, such as Shangdong, Zhejiang, Jiangsu, Henan, Hebei, etc., However, there are no vet APIs production enterprises in several provincial regions such as Qinghai, Tibet, Hainan, Yunnan, Guizhou, Beijing, etc. The distribution of vet APIs products also has regional characteristics. For example, the florfenicol manufacturers are mainly located in Hubei and Zhejiang provinces. If you want more information, don't hesitate to contact us.
So far, China can produce and supply to the global market about 160 varieties of vet APIs, of which Florfenicol and Tilmicosin are both produced by 19 manufacturers, followed by carbasalate calcium 17 manufacturers and Sulfamonomethoxine sodium 16 manufacturers.
China's veterinary APIs industry has once experienced a shift from centralized to decentralized, forming a blossoming situation throughout the country. Under the influence of many factors, such as increasingly strict environmental regulatory policies and rising costs, veterinary API companies have begun to move from coastal cities to remote inland areas. In the following ten years, the regional transfer of veterinary API production is expected to undergo another change.